Synthetic Antitumor Vaccines Containing MUC1 Glycopeptides with Two Immunodominant Domains-Induction of a Strong Immune Response against Breast Tumor Tissues

Retargeting of Human T Cells to Tumor-Associated MUC1: The Evolution of a Chimeric Antigen Receptor

(2014) S. Wilkie et al.   JOURNAL OF IMMUNOLOGY

Engineering O-Glycosylation Points in Non-extended Peptides: Implications for the Molecular Recognition of Short Tumor-Associated Glycopeptides

(2011) Francisco Corzana et al.   CHEMISTRY-A EUROPEAN JOURNAL

Synthetic Antitumor Vaccines from Tetanus Toxoid Conjugates of MUC1 Glycopeptides with the Thomsen-Friedenreich Antigen and a Fluorine-Substituted Analogue

(2010) Anja Hoffmann-Röder et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

MUC1 immunotherapy

(2010) Richard E Beatson et al.   Immunotherapy

A High-ThroughputO-Glycopeptide Discovery Platform for Seromic Profiling

(2010) Ola Blixt et al.   JOURNAL OF PROTEOME RESEARCH

Tumor-Associated MUC1 Tandem-Repeat Glycopeptide Microarrays to Evaluate Serum- and Monoclonal-Antibody Specificity

(2009) Ulrika Westerlind et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

A Synthetic Vaccine Consisting of a Tumor-Associated Sialyl-TN-MUC1 Tandem-Repeat Glycopeptide and Tetanus Toxoid: Induction of a Strong and Highly Selective Immune Response

(2009) Anton Kaiser et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

The Nature and Sequence of the Amino Acid Aglycone Strongly Modulates the Conformation and Dynamics Effects of Tn Antigen's Clusters

(2009) Francisco Corzana et al.   CHEMISTRY-A EUROPEAN JOURNAL

Synthetic Vaccines Consisting of Tumor-Associated MUC1 Glycopeptide Antigens and a T-Cell Epitope for the Induction of a Highly Specific Humoral Immune Response

(2008) Ulrika Westerlind et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes

(2008) Tanja Ninkovic et al.   MOLECULAR IMMUNOLOGY